SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001193125-13-262907
Filing Date
2013-06-18
Accepted
2013-06-18 17:21:16
Documents
13

Document Format Files

Seq Description Document Type Size
1 FORM F-1 d517182df1.htm F-1 2387557
2 EX-23.1 d517182dex231.htm EX-23.1 2017
3 GRAPHIC g517182g06y10.jpg GRAPHIC 37313
4 GRAPHIC g517182g36d61.jpg GRAPHIC 30822
5 GRAPHIC g517182g44k50.jpg GRAPHIC 50528
6 GRAPHIC g517182g60q01.jpg GRAPHIC 23229
7 GRAPHIC g517182g69p67.jpg GRAPHIC 86996
8 GRAPHIC g517182g74p89.jpg GRAPHIC 63586
9 GRAPHIC g517182g77c95.jpg GRAPHIC 23124
10 GRAPHIC g517182g82w61.jpg GRAPHIC 33007
11 GRAPHIC g517182g88p91.jpg GRAPHIC 72307
12 GRAPHIC g517182g88s00.jpg GRAPHIC 31618
13 GRAPHIC g517182g90c25.jpg GRAPHIC 42324
  Complete submission text file 0001193125-13-262907.txt   3074019
Mailing Address ONE KEW PLACE 150 ROUSE BOULEVARD PHILADELPHIA PA 19112
Business Address ONE KEW PLACE 150 ROUSE BOULEVARD PHILADELPHIA PA 19112 267-546-3003
Iroko Pharmaceuticals Inc. (Filer) CIK: 0001566717 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: F-1 | Act: 33 | File No.: 333-189428 | Film No.: 13920244
SIC: 2834 Pharmaceutical Preparations